![Christopher L. Reading](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher L. Reading
Director Técnico/Científico/I+D en Harbor Therapeutics, Inc. .
Fortuna: 16 939 $ al 31/05/2024
Perfil
Christopher L.
Reading is currently the Chief Scientific Officer at Harbor Therapeutics, Inc. He previously held positions as Vice President-Product & Process Development at Systemix, Inc. and Novartis, Inc. He also served as Chief Scientific Officer at Harbor Diversified, Inc. and was an Associate & Assistant Professor at The University of Texas M.D.
Anderson Cancer Center.
Reading holds a doctorate from the University of California, Berkeley and an undergraduate degree from the University of California San Diego.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BIOVIE INC. CLASS A
0.06% | 16/02/2023 | 37 148 ( 0.06% ) | 16 939 $ | 31/05/2024 |
Cargos activos de Christopher L. Reading
Empresas | Cargo | Inicio |
---|---|---|
Harbor Therapeutics, Inc.
![]() Harbor Therapeutics, Inc. BiotechnologyHealth Technology Harbor Therapeutics, Inc. develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health. The company is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | 01/01/1999 |
Antiguos cargos conocidos de Christopher L. Reading.
Empresas | Cargo | Fin |
---|---|---|
The University of Texas M.D. Anderson Cancer Center
![]() The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Novartis, Inc.
![]() Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
Systemix, Inc.
![]() Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | - |
HARBOR DIVERSIFIED, INC. | Director Técnico/Científico/I+D | - |
Formación de Christopher L. Reading.
University of California, Berkeley | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
HARBOR DIVERSIFIED, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Novartis, Inc.
![]() Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
Systemix, Inc.
![]() Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
The University of Texas M.D. Anderson Cancer Center
![]() The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
Harbor Therapeutics, Inc.
![]() Harbor Therapeutics, Inc. BiotechnologyHealth Technology Harbor Therapeutics, Inc. develops a proprietary class of adrenal steroid hormones as novel pharmaceuticals and nutraceuticals for human health. The company is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher L. Reading